BCL2 and B-cell chronic lymphocytic leukemia: In a chronic lymphocytic leukaemia (CLL) model, QCT was shown to restore the sensitivity of radio-resistant B-1 cells to apoptosis by lowering Bcl-2 expression, normalising miR15a/16 levels, and limiting their migration to the liver [96].